BIOMAT Database Logo BIOMAT Database Logo

Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. 2002

Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, Esapaña.

This paper describes the synthesis and the antiplatelet activity of a series of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. Some of these compounds show a dose-dependent activity and were found to be more active than their 5-substituted analogues.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
[Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
January 1990, Yao xue xue bao = Acta pharmaceutica Sinica,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. A series of hypotensive agents.
March 1974, Journal of medicinal chemistry,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
6-(Substituted phenyl)-5-substituted-4,5-dihydro-3(2H)-pyridazinones. Antihypertensive agents.
March 1974, Journal of medicinal chemistry,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Antihypertensive and antithrombotic activities of 6-(substituted phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)pyridazinones.
August 1987, Il Farmaco; edizione scientifica,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
[Studies on synthesis, anticonvulsant activity and the structure--activity relationships of 6-(substituted phenyl)-3 (2H) pyridazinones].
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Pyridazines. XVIII. 6-Aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets.
December 1999, Biological & pharmaceutical bulletin,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
July 1997, Chemical & pharmaceutical bulletin,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Synthesis of diverse 4,5-dihydro-3(2H)-pyridazinones on Wang resin.
July 2001, The Journal of pharmacy and pharmacology,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives.
January 2007, Arzneimittel-Forschung,
Eddy Sotelo, and Nuria Fraiz, and Matilde Yáñez, and Reyes Laguna, and Ernesto Cano, and Enrique Raviña
Synthesis and antifeedant activity of new oxadiazolyl 3(2H)-pyridazinones.
January 2003, Journal of agricultural and food chemistry,
Copied contents to your clipboard!